Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Pediatr Crit Care Med. 2016 Feb;17(2):101–109. doi: 10.1097/PCC.0000000000000613

Figure 4.

Figure 4

(A) AVDSf at 24 hours in patients not exposed and exposed to iNO. (B) ROC curve for discriminating mortality in patients not exposed to iNO (AUROC 0.64 (95% CI 0.50 to 0.78, p = 0.060). (C) ROC curve for discriminating mortality in patients exposed to iNO (AUROC 0.42 (95% CI 0.19 to 0.64, p = 0.386).